NO322254B1 - Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette. - Google Patents

Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette. Download PDF

Info

Publication number
NO322254B1
NO322254B1 NO19974322A NO974322A NO322254B1 NO 322254 B1 NO322254 B1 NO 322254B1 NO 19974322 A NO19974322 A NO 19974322A NO 974322 A NO974322 A NO 974322A NO 322254 B1 NO322254 B1 NO 322254B1
Authority
NO
Norway
Prior art keywords
hpv18
protein
dna
recombinant
dna molecule
Prior art date
Application number
NO19974322A
Other languages
English (en)
Norwegian (no)
Other versions
NO974322L (no
NO974322D0 (no
Inventor
Kathrin Ute Jansen
Hugh A George
Kathryn J Hofmann
Joseph G Joyce
Michael P Neeper
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO322254(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO974322D0 publication Critical patent/NO974322D0/no
Publication of NO974322L publication Critical patent/NO974322L/no
Publication of NO322254B1 publication Critical patent/NO322254B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20023Virus like particles [VLP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19974322A 1995-03-22 1997-09-19 Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette. NO322254B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine
PCT/US1996/003649 WO1996029413A2 (en) 1995-03-22 1996-03-18 Dna encoding human papilloma virus type 18

Publications (3)

Publication Number Publication Date
NO974322D0 NO974322D0 (no) 1997-09-19
NO974322L NO974322L (no) 1997-11-24
NO322254B1 true NO322254B1 (no) 2006-09-04

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974322A NO322254B1 (no) 1995-03-22 1997-09-19 Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette.

Country Status (22)

Country Link
EP (2) EP0817851B9 (de)
JP (1) JPH11502704A (de)
KR (1) KR100430698B1 (de)
CN (1) CN1100876C (de)
AT (1) ATE259879T1 (de)
AU (1) AU714533B2 (de)
CA (1) CA2215834C (de)
CZ (1) CZ291242B6 (de)
DE (4) DE69631586T9 (de)
DK (1) DK0817851T5 (de)
EA (1) EA001092B1 (de)
ES (1) ES2213772T3 (de)
FR (1) FR07C0023I2 (de)
HU (1) HU223761B1 (de)
IL (1) IL117459A (de)
NL (3) NL300273I1 (de)
NO (1) NO322254B1 (de)
NZ (1) NZ305188A (de)
PL (1) PL184022B1 (de)
PT (1) PT817851E (de)
SK (1) SK284281B6 (de)
WO (1) WO1996029413A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
ES2216280T3 (es) * 1997-04-08 2004-10-16 MERCK & CO., INC. Formulaciones estabilizadas de papilomavirus humano.
SI1105466T1 (sl) * 1998-08-14 2006-08-31 Merck & Co Inc Postopek za ciscenje virusu podobnih delcev humanega papilomskega virusa
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
SI1150712T1 (sl) 1999-02-05 2009-02-28 Merck & Co Inc Pripravek cepiva proti humanem papiloma virusu
FR2795074A1 (fr) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2008134935A1 (fr) * 2007-04-29 2008-11-13 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Protéines 18 l1 de type papillomavirus humain tronqué
BRPI0811016B1 (pt) 2007-04-29 2021-09-21 Xiamen Innovax Biotech Co., Ltd. Proteína li truncada do papiloma vírus humano tipo 16
CN101440373B (zh) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
CA2768172A1 (en) * 2009-06-25 2010-12-29 Glaxosmithkline Biologicals S.A. Novel compositions
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
US20150110824A1 (en) 2012-03-18 2015-04-23 Glaxosmithkline Biologicals, Sa Method of vaccination against human papillomavirus
CN108276491B (zh) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
US7476389B1 (en) * 1991-07-19 2009-01-13 The University Of Queensland Papillomavirus vaccines
DE122007000095I1 (de) * 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE122007000014I1 (de) * 1993-03-09 2007-05-24 Univ Rochester Herstellung von menschlichem Papillomavirus Hüllprotein und virus-ähnlichen Teilchen

Also Published As

Publication number Publication date
FR07C0023I1 (de) 2007-04-27
EP0817851B1 (de) 2004-02-18
DE122007000031I1 (de) 2007-07-19
WO1996029413A2 (en) 1996-09-26
DK0817851T3 (da) 2004-08-16
HUP9801334A2 (hu) 1998-08-28
NL300273I1 (nl) 2007-05-01
EP0817851A2 (de) 1998-01-14
SK284281B6 (sk) 2004-12-01
EP1422294A1 (de) 2004-05-26
CN1185176A (zh) 1998-06-17
AU5314196A (en) 1996-10-08
MX9707208A (es) 1997-11-29
DE69631586T2 (de) 2005-01-27
DE69631586D1 (de) 2004-03-25
PL322333A1 (en) 1998-01-19
ATE259879T1 (de) 2004-03-15
DE122007000025I1 (de) 2007-07-12
DE69631586T9 (de) 2005-06-16
CZ291242B6 (cs) 2003-01-15
DE122007000030I1 (de) 2007-07-19
KR100430698B1 (ko) 2004-07-15
NO974322L (no) 1997-11-24
IL117459A0 (en) 1996-07-23
FR07C0023I2 (fr) 2012-08-03
IL117459A (en) 2005-11-20
AU714533B2 (en) 2000-01-06
NL300271I1 (nl) 2007-05-01
HUP9801334A3 (en) 1999-04-28
JPH11502704A (ja) 1999-03-09
CA2215834C (en) 2007-06-12
EA199700256A1 (ru) 1999-06-24
SK127897A3 (en) 1998-07-08
WO1996029413A3 (en) 1996-11-28
CZ293697A3 (cs) 1998-02-18
DK0817851T5 (da) 2004-10-25
HU223761B1 (hu) 2005-01-28
EP0817851B9 (de) 2004-08-18
NO974322D0 (no) 1997-09-19
ES2213772T3 (es) 2004-09-01
PT817851E (pt) 2004-06-30
NZ305188A (en) 1999-11-29
PL184022B1 (pl) 2002-08-30
EA001092B1 (ru) 2000-10-30
CN1100876C (zh) 2003-02-05
CA2215834A1 (en) 1996-09-26
NL300272I1 (nl) 2007-05-01

Similar Documents

Publication Publication Date Title
US5840306A (en) DNA encoding human papillomavirus type 18
EP0817852B1 (de) Synthetisches, hpv6/11 hybrides l1 dns, das für menschliches papillomavirus typ 11 l1-protein kodiert
US5820870A (en) Recombinant human papillomavirus type 18 vaccine
NO322133B1 (no) Fremgangsmate for fremstilling av rensede viruslignende partikler (VLP-er) av humant papillomavirus.
US5821087A (en) Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
NO322254B1 (no) Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette.
RU2161651C2 (ru) Очищенные белки вируса папилломы
WO1996015247A9 (en) Purified papillomavirus proteins
US6908615B1 (en) DNA encoding human papilloma virus type 18
CA2216827C (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
CA2204266C (en) Purified papillomavirus proteins
MXPA97007208A (en) Desoxirribonucleico acid that codifies for human papilloma virus type 18 and use of my

Legal Events

Date Code Title Description
MK1K Patent expired